The Food and Drug Administration (FDA) has published a notice soliciting comments on its draft "Prescription Drug User Fee Act (PDUFA) IV Drug Safety Five-Year Plan." The plan focuses on implementation PDUFA performance goals related to Enhancement and Modernization of the FDA Drug Safety System, and Review of Proprietary Names to Reduce Medication Errors. Comments will be accepted until June 19.